Gabelli & Co Investment Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$322K Hold
350
0.05% 200
2025
Q4
$376K Sell
350
-50
-13% -$47.8K 0.06% 176
2025
Q3
$305K Buy
+400
New +$298K 0.05% 187
2016
Q4
Sell
-3,000
Closed -$241K 163
2016
Q3
$241K Sell
3,000
-3,000
-50% -$240K 0.03% 144
2016
Q2
$473K Sell
6,000
-4,000
-40% -$301K 0.06% 114
2016
Q1
$720K Sell
10,000
-3,000
-23% -$227K 0.09% 90
2015
Q4
$1.09M Buy
+13,000
New +$1.08M 0.13% 77

Other funds holding LLY

Gabelli & Co Investment Advisers's LLY Position: Q1 2026 in Review

Gabelli & Co Investment Advisers held its Eli Lilly (LLY) position steady in Q1 2026 at 350 shares worth $322K. The position accounts for 0.05% of the portfolio, ranked #200.

Gabelli & Co Investment Advisers first reported a position in LLY in Q4 2015 and has held it in 7 quarters since. The position peaked at $1.09M in Q4 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gabelli & Co Investment Advisers held 350 shares of Eli Lilly worth $322K as of Q1 2026.
  • Gabelli & Co Investment Advisers left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.05% of Gabelli & Co Investment Advisers's portfolio in Q1 2026, its #200 holding.
  • Gabelli & Co Investment Advisers first reported a position in Eli Lilly in Q4 2015 and has held it in 7 quarters since.
  • Gabelli & Co Investment Advisers's Eli Lilly position peaked at $1.09M in Q4 2015.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.